Andrew M Scott, MBBS
Austin Health · Ludwig Institute for Cancer Research & Austin Health · Ludwig Institute for Cancer Research
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrew M Scott, MBBS as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:35 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04297748 · Bioimaging Study of 89Zr-M7824 in NSCLCOlivia Newton-John Cancer Research Institute · terminated · Non-Small Cell Lung Cancer · principal investigator
- Ph1NCT01220999 · A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal CancerLudwig Institute for Cancer Research · completed · Colorectal Neoplasms · principal investigator
- Ph1NCT00293215 · Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y AntigenLudwig Institute for Cancer Research · terminated · Neoplasms · principal investigator
- Ph1NCT00291486 · Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal CancerLudwig Institute for Cancer Research · completed · Colorectal Neoplasms · principal investigator
- Ph1NCT00291447 · 111In-ch806 in Patients With Advanced Tumours Expressing the 806 AntigenLudwig Institute for Cancer Research · completed · Neoplasms · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Phase l study of 131 I-HuA33 with oral capecitabine in*R21CA108145 · NCI · LUDWIG INSTITUTE FOR CANCER RESEARCH · PI ANDREW M SCOTT · fiscal years 2005 to 2006Named on NCT00291486
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.